(17-ß)-3-oxoandrost-4-en-17-yl tridecanoate compositions and methods of their preparation and use
AssigneeLipocine Inc.
InventorsMahesh V. Patel, Nachiappan Chidambaram, Satish Kumar Nachaegari, Srinivasan Venkateshwaran, Joel Frank, Amy Jo Portlock
Life of this patent
Estimating the term…
Abstract
Described here are substantially pure (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate compositions, methods of their preparation and uses thereof.
Claims32
Substantially pure (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate suitable for administration to human subject in need of (17-β)-hydroxy androst-4-en-3-one.
A pharmaceutical composition comprising or made from a substantially pure (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate and a pharmaceutically acceptable carrier for administration to human subject in need of (17-β)-hydroxy-4-androsten-3-one.
31-34. (canceled)
Dependencies are inferred from the claim text.